Delaware
|
001-36498
|
86-1032927
|
||
(State or other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
19925 Stevens Creek Blvd., Suite 100
Cupertino, California
|
95014
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Nominee
|
Shares Voted For
|
Shares Withheld
|
||
Wen Tao (Steve) Liu
|
7,849,055
|
422,511
|
||
Nadir Patel
|
7,919,246
|
352,320
|
||
Wei (William) Cao
|
7,046,621
|
1,224,945
|
Shares Voted For
|
Shares Voted Against
|
Shares Abstaining
|
||
7,895,988
|
851
|
374,727
|
Cellular Biomedicine Group, Inc.
|
|||
Date: November 30, 2015
|
By:
|
/s/ Bizuo (Tony) Liu | |
Bizuo (Tony) Liu | |||
Chief Financial Officer | |||